Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

At the J.P. Morgan Healthcare Conference, the Biotech Sisterhood assembled in Union Square to showcase the large group of ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.